Young synovial mesenchymal stem cell-derived exosomes restore chondrocyte mitophagy and alleviate osteoarthritis by delivering miR-10a-5p to target CRTAC1

Osteoarthritis (OA) is a chronic whole-joint degenerative disease. Synovial mesenchymal stem cells (SMSCs) and their derived exosomes (SMSC-Exos) have attracted increasing attention because of their close interaction with the joint microenvironment and their paracrine regenerative potential. However, whether donor aging compromises the cartilage-reparative capacity of SMSC-Exos and the key molecular mechanisms underlying this effect remain unclear. Human SMSCs from young and aged donors were isolated and cultured by enzymatic digestion and plastic-adherence selection, and SMSC-Exos were obtained by ultracentrifugation. Exosomes were characterized by transmission electron microscopy, nanoparticle tracking analysis (NTA), exosomal marker detection, and uptake assays. Using an IL-1β-induced human chondrocyte injury model and a destabilization of the medial meniscus (DMM)-induced male mouse OA model, we systematically evaluated the effects of young- and aged-donor SMSC-Exos and intra-articularly delivered synovial cell-targeted AAV-miR-10a-5p on chondrocyte proliferation, migration, apoptosis, oxidative stress, mitochondrial function, matrix metabolism, and OA progression. Exosomal miRNA sequencing, qRT-PCR, dual-luciferase reporter assays, CRTAC1 overexpression rescue experiments, and mitophagy assays were integrated to explore the mechanism of the miR-10a-5p/CRTAC1 axis. Aged donor-derived SMSCs exhibited senescence-associated alterations, including increased cell size, a higher proportion of SA-β-gal-positive cells, and elevated P16, P21, and P53 expression, but retained MSC surface markers and multilineage differentiation capacity. SMSC-Exos from both young and aged donors displayed typical vesicular morphology and were internalized by chondrocytes; however, Young-Exos were superior to Aged-Exos in promoting chondrocyte proliferation and migration, reducing IL-1β-induced apoptosis and ROS accumulation, and restoring mitochondrial membrane potential and mitochondrial network integrity. In vivo, Young-Exos more effectively improved gait abnormalities, pain-related behavior, osteophyte formation, cartilage proteoglycan loss, and COL2A1/MMP-13 imbalance in OA mice than Aged-Exos. miRNA sequencing identified miR-10a-5p as a Young-Exos-enriched candidate associated with autophagy, mitochondrial function, and inflammatory pathways. Mechanistically, miR-10a-5p suppressed CRTAC1 by binding to the human CRTAC1 3′UTR reporter and reduced CRTAC1 expression in chondrocytes. miR-10a-5p increased Parkin and LC3B expression, decreased p62 accumulation, promoted mitochondria-lysosome colocalization, restored COL II and ACAN expression, and inhibited MMP13, whereas CRTAC1 overexpression partially reversed these protective effects. Synovium-targeted intra-articular delivery of AAV-miR-10a-5p reduced CRTAC1 and NLRP3 levels, restored LC3B-associated mitophagy signaling, decreased p62 accumulation, and attenuated DMM-induced cartilage degeneration and synovitis. Donor aging weakens the cartilage-repair potential of SMSC-Exos by reshaping their miRNA cargo. miR-10a-5p enriched in Young-Exos targets CRTAC1, thereby relieving CRTAC1-associated mitochondrial dysfunction and impaired mitophagy, restoring chondrocyte matrix homeostasis, and delaying OA progression. These findings provide a new rationale for donor selection and miRNA engineering in SMSC-Exos–based cell-free therapy for OA.

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2026-11-16
DOI
https://doi.org/10.1186/s12951-026-05268-3
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Young synovial mesenchymal stem cell-derived exosomes restore chondrocyte mitophagy and alleviate osteoarthritis by delivering miR-10a-5p to target CRTAC1

Hanhao Dai, 苏亦斌, Yu Xiu, Yan Tang et al.
Journal of Nanobiotechnology
Osteoarthritis Treatment and Mechanisms
article

Young synovial mesenchymal stem cell-derived exosomes restore chondrocyte mitophagy and alleviate osteoarthritis by delivering miR-10a-5p to target CRTAC1

Hanhao Dai, 苏亦斌, Yu Xiu, Yan Tang, Jun Luo, Zhao Lin, Linhai Yang, Guoyu Yu, Jie Xu, Rongsheng Zhang, Zhibo Deng, Mao Nie, Chao Song
article en

Abstract

Osteoarthritis (OA) is a chronic whole-joint degenerative disease. Synovial mesenchymal stem cells (SMSCs) and their derived exosomes (SMSC-Exos) have attracted increasing attention because of their close interaction with the joint microenvironment and their paracrine regenerative potential. However, whether donor aging compromises the cartilage-reparative capacity of SMSC-Exos and the key molecular mechanisms underlying this effect remain unclear. Human SMSCs from young and aged donors were isolated and cultured by enzymatic digestion and plastic-adherence selection, and SMSC-Exos were obtained by ultracentrifugation. Exosomes were characterized by transmission electron microscopy, nanoparticle tracking analysis (NTA), exosomal marker detection, and uptake assays. Using an IL-1β-induced human chondrocyte injury model and a destabilization of the medial meniscus (DMM)-induced male mouse OA model, we systematically evaluated the effects of young- and aged-donor SMSC-Exos and intra-articularly delivered synovial cell-targeted AAV-miR-10a-5p on chondrocyte proliferation, migration, apoptosis, oxidative stress, mitochondrial function, matrix metabolism, and OA progression. Exosomal miRNA sequencing, qRT-PCR, dual-luciferase reporter assays, CRTAC1 overexpression rescue experiments, and mitophagy assays were integrated to explore the mechanism of the miR-10a-5p/CRTAC1 axis. Aged donor-derived SMSCs exhibited senescence-associated alterations, including increased cell size, a higher proportion of SA-β-gal-positive cells, and elevated P16, P21, and P53 expression, but retained MSC surface markers and multilineage differentiation capacity. SMSC-Exos from both young and aged donors displayed typical vesicular morphology and were internalized by chondrocytes; however, Young-Exos were superior to Aged-Exos in promoting chondrocyte proliferation and migration, reducing IL-1β-induced apoptosis and ROS accumulation, and restoring mitochondrial membrane potential and mitochondrial network integrity. In vivo, Young-Exos more effectively improved gait abnormalities, pain-related behavior, osteophyte formation, cartilage proteoglycan loss, and COL2A1/MMP-13 imbalance in OA mice than Aged-Exos. miRNA sequencing identified miR-10a-5p as a Young-Exos-enriched candidate associated with autophagy, mitochondrial function, and inflammatory pathways. Mechanistically, miR-10a-5p suppressed CRTAC1 by binding to the human CRTAC1 3′UTR reporter and reduced CRTAC1 expression in chondrocytes. miR-10a-5p increased Parkin and LC3B expression, decreased p62 accumulation, promoted mitochondria-lysosome colocalization, restored COL II and ACAN expression, and inhibited MMP13, whereas CRTAC1 overexpression partially reversed these protective effects. Synovium-targeted intra-articular delivery of AAV-miR-10a-5p reduced CRTAC1 and NLRP3 levels, restored LC3B-associated mitophagy signaling, decreased p62 accumulation, and attenuated DMM-induced cartilage degeneration and synovitis. Donor aging weakens the cartilage-repair potential of SMSC-Exos by reshaping their miRNA cargo. miR-10a-5p enriched in Young-Exos targets CRTAC1, thereby relieving CRTAC1-associated mitochondrial dysfunction and impaired mitophagy, restoring chondrocyte matrix homeostasis, and delaying OA progression. These findings provide a new rationale for donor selection and miRNA engineering in SMSC-Exos–based cell-free therapy for OA.

Journal of Nanobiotechnology
Fujian University of Traditional Chinese Medicine (CN), Fujian Medical University (CN), Second Affiliated Hospital of Chongqing Medical University (CN), Fuzhou University (CN)
Good health and well-being
Osteoarthritis Treatment and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon